日韩生物产业政策浅析

A brief analysis of Japanese and South Korean bio-industry policies

日韩作为亚洲生物产业的先行者和领头羊,其生物科技产业相关政策的指导和调控卓有成效,各具特色。日本在生物技术和产业领域位居世界前列,政府通过优化发展战略、加大投入力度、促进官产学结合、注重产品转化和市场预期等方式,推动生物产业发展。韩国生物产业发展迅猛,其政策从明确战略重点、科学规划管理、支持科创成果产业化、运营合作多样化等方面引导和促进产业壮大。综述了日韩生物产业政策的历史及现状,结合其国情和优、劣势,对其未来政策方向和重点进行了分析,以期对我国生物产业发展起借鉴作用。

As pioneers and bellwethers of Asian biotechnology industry, Japan and South Korea have exercised effective and characteristic guidance and control of their bio-industry policies. Japan stands at the forefront of the world in both biotechnology and bio-industry, its govenament optimizing development strategies for increasing investment, promoting the combination of govenament and business and research, focusing on product-commodity conversion and market expectation, while South Korea has been develop- ing rapidly in bio-industry, its policies being characteristic of clear strategic focus, scientific planning and management, industrial- ization of scientific and technological achievements and diversified operation modes. On the basis of reviewing the history and current status of the two countries＇ bio-indusutry policies and combining their national conditions, advantages and disadvantages, this paper analyzes their future policies direction and priolity in the hope of providing references for China＇s bio-industry development.